This pilot study investigated the feasibility of detecting mutations in exons 5–8 of the p53 gene using single-stranded conformational polymorphism (SSCP) analysis in bladder-washing specimens from patients with bladder cancer. Here, TP53 is linked to urinary bladder cancer.